bpc-157 fda Big news for the peptide space., The Pharmacy Compounding Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to FDA panel votes to place

A 2019 study in malabsorption syndrome confirmed sublingual forms raised levels 2x faster than oral cyanocobalamin

Not what influencers say

Speak with a medical expert to determine whether you should receive peptide therapy

B12 injections are contraindicated for individuals with Lebers hereditary optic neuropathy, severe kidney disease, known cobalt or cobalamin allergy, and polycythemia vera

Most clinics add vitamin B12 (cyanocobalamin or methylcobalamin) to the blend and administer the whole thing as a single intramuscular or subcutaneous injection, which is why MIC injections and MIC B12 injections usually refer to the same product